As the primary protein component of plasma HDL, constituting roughly 70% of its protein content, APOA-I has been extensively studied for its functions in modulating lipid homeostasis and its therapeutic potential in cardiovascular disease management [82]. The gene discussed is APOA1; the disease is cardiovascular disorder.